The so-called Stage II laryngeal cancer refers to the degree of differentiation of cancer cells, classified as moderately malignant. This type of differentiated cancer cells has a tumor growth rate that is between Stage I and Stage III, and shows certain characteristics of invasion and metastasis. Stage II laryngeal cancer generally tends to metastasize via the lymphatic pathways, and some patients may also experience hematogenous pathway metastasis. Clinically, patients with Stage II laryngeal cancer may present with symptoms localized to the larynx as well as symptoms of metastatic sites. Patients may experience symptoms such as hoarseness, cough, expectoration, and a foreign body sensation in the throat. When metastasis occurs, respiratory symptoms like coughing and coughing up blood can appear.